ALXN1210 Versus Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab
Clinical trial NCT03056040 · COMPLETED
Trial details
- NCT number
- NCT03056040
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-17
- Primary completion
- 2022-02-21
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.